{
  "guideline": {
    "id": "PA166182810",
    "name": "Annotation of DPWG Guideline for flucloxacillin and HLA-B",
    "relatedChemicals": [
      {
        "id": "PA164781042",
        "name": "flucloxacillin",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA35056",
        "name": "major histocompatibility complex, class I, B",
        "symbol": "HLA-B"
      }
    ],
    "source": "DPWG",
    "recommendation": true,
    "guidelineGenes": [
      {
        "alleles": [
          {
            "id": 1451417601,
            "_label": "*57:01:01",
            "function": {
              "term": "Presence",
              "termId": "haplotypeTags:1445558333"
            }
          },
          {
            "id": 1451417590,
            "_label": "Other",
            "function": {
              "term": "Absence",
              "termId": "haplotypeTags:1445558334"
            }
          }
        ],
        "gene": {
          "chr": {
            "id": "PA532",
            "name": "chr6",
            "symbol": null
          },
          "strand": "minus",
          "id": "PA35056",
          "name": "major histocompatibility complex, class I, B",
          "symbol": "HLA-B"
        }
      }
    ],
    "@id": "https://pharmgkb.org/guidelineAnnotation/PA166182810",
    "version": 6
  },
  "annotationGroups": [
    {
      "id": "PA166240541",
      "name": "*57:01 negative",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "No",
        "termId": "rxChange:1448602495"
      },
      "genePhenotypes": [
        "HLA-B:Absence/Absence"
      ],
      "metabolizerStatus": null,
      "recommendation": {
        "id": 1451782571,
        "html": "<p>The guideline does not provide a recommendation for flucloxacillin in patients with no HLA-B*57:01 alleles or negative for the.HLA-B*57:01 test.</p>\n"
      },
      "implications": {
        "id": 1451782570,
        "html": "<p>The guideline does not provide a description of the impact of the absence of HLA-B*57:01 alleles on flucloxacillin.</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166240542",
      "name": "*57:01 positive",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "Possibly",
        "termId": "rxChange:1448602496"
      },
      "genePhenotypes": [
        "HLA-B:Absence/Presence",
        "HLA-B:Presence/Presence"
      ],
      "metabolizerStatus": null,
      "recommendation": {
        "id": 1451782569,
        "html": "<ol>\n<li>Regularly monitor the patientâ€™s liver function</li>\n<li>Choose an alternative if liver enzymes and/or bilirubin levels are elevated</li>\n</ol>\n"
      },
      "implications": {
        "id": 1451782568,
        "html": "<p>HLA-B*57:01-positive patients have an 80-fold elevated risk of flucloxacillin-induced liver injury. However, the incidence is low (1-2 per 1000 individuals).</p>\n"
      },
      "activityScore": null
    }
  ],
  "citations": []
}